These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11055774)

  • 1. Evaluation of 2LHERP in preventing recurrences of genital herpes. Institut International 3IDI.
    Jenaer M; Henry MF; Garcia A; Marichal B
    Br Homeopath J; 2000 Oct; 89(4):174-7. PubMed ID: 11055774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.
    Le Cleach L; Trinquart L; Do G; Maruani A; Lebrun-Vignes B; Ravaud P; Chosidow O
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009036. PubMed ID: 25086573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection.
    Hollier LM; Wendel GD
    Cochrane Database Syst Rev; 2008 Jan; (1):CD004946. PubMed ID: 18254066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.
    Scott LL; Hollier LM; McIntire D; Sanchez PJ; Jackson GL; Wendel GD
    Infect Dis Obstet Gynecol; 2001; 9(2):75-80. PubMed ID: 11495557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimizing recurrences of genital herpes--a role for suppressive antiviral therapy.
    Remington M
    JAAPA; 2004 Aug; 17(8):19-24. PubMed ID: 15357167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Famciclovir treatment options for patients with frequent outbreaks of recurrent genital herpes: the RELIEF trial.
    Bartlett BL; Tyring SK; Fife K; Gnann JW; Hadala JT; Kianifard F; Berber E
    J Clin Virol; 2008 Oct; 43(2):190-5. PubMed ID: 18621575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group.
    Mertz GJ; Loveless MO; Levin MJ; Kraus SJ; Fowler SL; Goade D; Tyring SK
    Arch Intern Med; 1997 Feb; 157(3):343-9. PubMed ID: 9040303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time.
    Benedetti JK; Zeh J; Corey L
    Ann Intern Med; 1999 Jul; 131(1):14-20. PubMed ID: 10391810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of recurrent genital herpes: a survey of UK genitourinary medicine clinics in 2003.
    Hamill M; Goldmeier D
    Int J STD AIDS; 2005 Nov; 16(11):760-2. PubMed ID: 16303073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study.
    Kim HN; Wald A; Harris J; Almekinder J; Heitman C; Corey L
    Sex Transm Dis; 2008 Feb; 35(2):124-8. PubMed ID: 17921912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing genital herpes infections in pregnancy.
    Gardella C; Brown ZA
    Cleve Clin J Med; 2007 Mar; 74(3):217-24. PubMed ID: 17375803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of acyclovir suppression to prevent recurrent genital herpes in term pregnancy.
    Scott LL; Alexander J
    Am J Perinatol; 1998 Jan; 15(1):57-62. PubMed ID: 9475690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
    Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A
    Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and prevention of herpes genital infection.
    Mindel A
    J Antimicrob Chemother; 1984 Aug; 14 Suppl A():75-83. PubMed ID: 6386788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial.
    Sheffield JS; Hill JB; Hollier LM; Laibl VR; Roberts SW; Sanchez PJ; Wendel GD
    Obstet Gynecol; 2006 Jul; 108(1):141-7. PubMed ID: 16816068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group.
    Diaz-Mitoma F; Sibbald RG; Shafran SD; Boon R; Saltzman RL
    JAMA; 1998 Sep; 280(10):887-92. PubMed ID: 9739972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the activity and safety of CS21 barrier genital gel® compared to topical aciclovir and placebo in symptoms of genital herpes recurrences: a randomized clinical trial.
    Khemis A; Duteil L; Tillet Y; Dereure O; Ortonne JP
    J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1158-64. PubMed ID: 24010876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient and partner perceptions about preventing genital herpes transmission.
    Gilbert L; Scanlon K; Peterson R; Ebel C
    Herpes; 2005 Dec; 12(3):60-5. PubMed ID: 16393521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genital herpes.
    Gupta R; Warren T; Wald A
    Lancet; 2007 Dec; 370(9605):2127-37. PubMed ID: 18156035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.